{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T14:13:41Z","timestamp":1773324821745,"version":"3.50.1"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["NeuroToxicology"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1016\/j.neuro.2017.05.001","type":"journal-article","created":{"date-parts":[[2017,5,6]],"date-time":"2017-05-06T22:45:15Z","timestamp":1494110715000},"page":"1-5","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Capecitabine-induced acute toxic leukoencephalopathy"],"prefix":"10.1016","volume":"62","author":[{"given":"M.","family":"Obadia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Leclercq","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Wasserman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Galanaud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Dormont","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Sahli-Amor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Psimaras","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Pyatigorskaya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Law-ye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuro.2017.05.001_bib0005","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1093\/jjco\/hyq157","article-title":"Early detection of 5-FU-induced acute leukoencephalopathy on diffusion-weighted MRI","volume":"41","author":"Akitake","year":"2011","journal-title":"Jpn. J. Clin. Oncol."},{"key":"10.1016\/j.neuro.2017.05.001_bib0010","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1136\/jnnp.2007.123737","article-title":"Delayed leukoencephalopathy with stroke-like presentation in chemotherapy recipients","volume":"79","author":"Baehring","year":"2008","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.neuro.2017.05.001_bib0015","article-title":"Capecitabine induced multifocal leukoencephalopathy: do we have always to switch off the chemotherapy?","volume":"240826","author":"Bougea","year":"2016","journal-title":"Case Rep. Oncol. Med."},{"key":"10.1016\/j.neuro.2017.05.001_bib0020","doi-asserted-by":"crossref","first-page":"121","DOI":"10.3816\/CCC.2003.n.019","article-title":"Capecitabine-related neurotoxicity presenting as trismus","volume":"3","author":"Couch","year":"2003","journal-title":"Clin. Colorectal Cancer"},{"key":"10.1016\/j.neuro.2017.05.001_bib0025","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1177\/0883073809346349","article-title":"Hyperperfusion on magnetic resonance imaging in acute chemotherapy-related leukoencephalopathy","volume":"25","author":"El-Hakam","year":"2010","journal-title":"J. Child Neurol."},{"key":"10.1016\/j.neuro.2017.05.001_bib0030","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1536\/ihj.54.417","article-title":"Capecitabine induces both cardiomyopathy and multifocal cerebral leukoencephalopathy","volume":"54","author":"Endo","year":"2013","journal-title":"Int. Heart J."},{"key":"10.1016\/j.neuro.2017.05.001_bib0035","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1177\/1078155210374891","article-title":"Toxic encephalopathy in elderly patients during treatment with capecitabine: literature review and a case report","volume":"17","author":"Fantini","year":"2011","journal-title":"J. Oncol. Pharm. Pract. Off. Publ. Int. Soc. Oncol. Pharm. Pract."},{"key":"10.1016\/j.neuro.2017.05.001_bib0040","first-page":"1686","article-title":"Diffusion-weighted MR imaging of early methotrexate-related neurotoxicity in children","volume":"26","author":"Fisher","year":"2005","journal-title":"Am. J. Neuroradiol."},{"key":"10.1016\/j.neuro.2017.05.001_bib0045","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1007\/s00280-005-0159-4","article-title":"5-Fluorouracil can cross brain-blood barrier and cause encephalopathy: should we expect the same from capecitabine? A case report on capecitabine-induced central neurotoxicity progressing to coma","volume":"58","author":"Formica","year":"2006","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.neuro.2017.05.001_bib0050","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/jbiol69","article-title":"Systemic 5-fluorouracil treatment causes a syndrome of delayed myelin destruction in the central nervous system","volume":"7","author":"Han","year":"2008","journal-title":"J. Biol."},{"key":"10.1016\/j.neuro.2017.05.001_bib0055","first-page":"626","article-title":"Severe toxicity after treatment with capecitabine and fluorouracil due to partial dihydropyrimidine dehydrogenase deficiency","volume":"148","author":"Hooiveld","year":"2004","journal-title":"Ned. Tijdschr. Geneeskd."},{"key":"10.1016\/j.neuro.2017.05.001_bib0060","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.neuro.2014.02.010","article-title":"Subacute reversible toxic encephalopathy related to treatment with capecitabine: a case report with literature review and discussion of pathophysiology","volume":"42","author":"Lyros","year":"2014","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.neuro.2017.05.001_bib0065","doi-asserted-by":"crossref","first-page":"e191","DOI":"10.1212\/WNL.0b013e3182904d03","article-title":"Teaching NeuroImages: 5-FU-induced acute leukoencephalopathy","volume":"80","author":"Mehta","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.neuro.2017.05.001_bib0070","first-page":"137","article-title":"Leukoencephalopathy caused by antineoplastic drugs","volume":"60","author":"Mizutani","year":"2008","journal-title":"Brain Nerve Shinkei Kenky\u016b No Shinpo"},{"key":"10.1016\/j.neuro.2017.05.001_bib0075","first-page":"216","article-title":"Diffusion-weighted imaging of acute excitotoxic brain injury","volume":"26","author":"Moritani","year":"2005","journal-title":"Am. J. Neuroradiol."},{"key":"10.1016\/j.neuro.2017.05.001_bib0080","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1159\/000078335","article-title":"Toxic encephalopathy induced by capecitabine","volume":"66","author":"Niemann","year":"2004","journal-title":"Oncology"},{"key":"10.1016\/j.neuro.2017.05.001_bib0085","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.nmd.2012.04.004","article-title":"Nerve, muscle and heart acute toxicity following oxaliplatin and capecitabine treatment","volume":"22","author":"Orsucci","year":"2012","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.neuro.2017.05.001_bib0090","doi-asserted-by":"crossref","first-page":"135","DOI":"10.4103\/0022-3859.113845","article-title":"Diffusion weighted MR imaging of 5-fluorouracil and oxaliplatin-induced leukoencephalopathy","volume":"59","author":"Paul","year":"2013","journal-title":"J. Postgrad. Med."},{"key":"10.1016\/j.neuro.2017.05.001_bib0095","doi-asserted-by":"crossref","first-page":"70","DOI":"10.3816\/CCC.2006.n.024","article-title":"Capecitabine-induced cerebellar toxicity","volume":"6","author":"Renouf","year":"2006","journal-title":"Clin. Colorectal Cancer"},{"key":"10.1016\/j.neuro.2017.05.001_bib0100","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1097\/00001813-200409000-00005","article-title":"Peripheral neuropathy associated with capecitabine","volume":"15","author":"Saif","year":"2004","journal-title":"Anticancer Drugs"},{"key":"10.1016\/j.neuro.2017.05.001_bib0105","first-page":"2014","article-title":"Atypical reversible leucoencephalopathy syndrome after Bevacizumab\/Folfox regimen for metastatic colon cancer","author":"Salmi","year":"2014","journal-title":"Case Rep. Oncol. Med."},{"key":"10.1016\/j.neuro.2017.05.001_bib0110","first-page":"1251","article-title":"Early diagnosis of capecitabine-induced acute leukoencephalopathy by using diffusion-weighted MRI","volume":"41","author":"Shimoyama","year":"2014","journal-title":"Gan To Kagaku Ryoho"},{"key":"10.1016\/j.neuro.2017.05.001_bib0115","first-page":"477","article-title":"Severe neurotoxicity following 5-fluorouracil-based chemotherapy in a patient with dihydropyrimidine dehydrogenase deficiency","volume":"2","author":"Takimoto","year":"1996","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.neuro.2017.05.001_bib0120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3941\/jrcr.v10i3.2686","article-title":"Capecitabine-induced leukoencephalopathy involving the bilateral corticospinal tracts","volume":"10","author":"Tan","year":"2016","journal-title":"J. Radiol. Case Rep."},{"key":"10.1016\/j.neuro.2017.05.001_bib0125","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1177\/1078155209102511","article-title":"Encephalopathy secondary to capecitabine chemotherapy: a case report and discussion","volume":"15","author":"Tipples","year":"2009","journal-title":"J. Oncol. Pharm. Pract. Off. Publ. Int. Soc. Oncol. Pharm. Pract."},{"key":"10.1016\/j.neuro.2017.05.001_bib0130","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1212\/01.wnl.0000187313.83515.7e","article-title":"Capecitabine-induced multifocal leukoencephalopathy: a report of five cases","volume":"65","author":"Videnovic","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.neuro.2017.05.001_bib0135","doi-asserted-by":"crossref","first-page":"251","DOI":"10.5692\/clinicalneurol.52.251","article-title":"Late-onset leukoencephalopathy induced by long-term chemotherapy with capecitabine and cyclophosphamide for liver metastasis from breast cancer","volume":"52","author":"Yasaki","year":"2012","journal-title":"Rinsh\u014d Shinkeigaku Clin. Neurol."},{"key":"10.1016\/j.neuro.2017.05.001_bib0140","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1038\/bjc.1997.79","article-title":"High-dose 5-fluorouracil infusional therapy is associated with hyperammonaemia, lactic acidosis and encephalopathy","volume":"75","author":"Yeh","year":"1997","journal-title":"Br. J. Cancer"}],"container-title":["NeuroToxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161813X17300724?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161813X17300724?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,23]],"date-time":"2023-08-23T12:58:03Z","timestamp":1692795483000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161813X17300724"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":28,"alternative-id":["S0161813X17300724"],"URL":"https:\/\/doi.org\/10.1016\/j.neuro.2017.05.001","relation":{},"ISSN":["0161-813X"],"issn-type":[{"value":"0161-813X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Capecitabine-induced acute toxic leukoencephalopathy","name":"articletitle","label":"Article Title"},{"value":"NeuroToxicology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuro.2017.05.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}